Scleromyxedema is a chronic, progressive condition characterized by confluent lichenoid eruption. It is usually associated with paraproteinemia. We present the case of 52 years old man diagnosed scleromyxedema without malignancy and paraproteinemia and treated with oral methotrexate and betamethasone.
INTRODUCTION
Scleromxyedema is rare disease affecting men and women. It is chronic progressive condition characterized by dermal fibrosis and mucinosis. It is almost always associated with monoclonal paraproteinemia usually immunoglobulin G type. Herein we present the case of a 52 years old man with classical cutaneous features of scleromyxedema. This was confirmed by H&E (Hematoxylin and eosin stain) and special stain through skin biopsy. However no evidence of malignancy was obtained in spite of intensive investigations. This case is being presented due to the rare occurrence of scleromyxedema in absence of malignancy.
CASE REPORT
A 52 years old male patient presented with history of skin lesions all over body and progressive tightening of skin over face and body since 10-12 years. He gave history of difficulty in mouth opening and difficulty in swallowing. However there was no history of photosensitivity, Raynaud's phenomenon, muscle weakness or weight loss. The patient had received multiple treatments since the last 3-4 months to no avail. On examination, skin over face showed waxy translucent papules with loss of lateral one third of bilateral eyebrows. Waxy papules seen over upper back, bilateral retroauricular area and pinnae, (Figure 1a ) resulting in stony hard feel of both pinnae. (Figure 1b ) Skin was taut to touch with mouth opening reduced to two fingers. There was diffuse tightening of skin underlying the papules over the entire trunk. (Figure 2a ) Loose folds of skin were seen over bilateral axilla, back, and groin. (Figure 2b ) Patient was unable to flex the fingers of both hands due to tightening of skin over dorsum of both hands. There were no stellate ulcers, neither any evidence of calcinosis. Nail discoloration and nail dystrophy was seen over toe nails. Multiple systemic disorders such as neurological, cardiac, ophthalmological disorders, renal, muscular (proximal myopathy), gastrointestinal (esophageal dysmotility), and pulmonary are frequent associations. All of these together may result in severe disability and may be fatal in some cases. 2 It never affects mucous membranes and rarely affects the scalp. It is also known as the Arndt-Gottron syndrome or generalized lichen myxedematosus. 3 Paraproteinemia is most common feature of Scleromyxedema. In 80% patients, monoclonal gammopathy is IgG with lambda light chains type. 3 Atypical cases of lichen myxedematosus have been reported with absence of monoclonal gammopathy, albeit with the plethora of cutaneous and systemic clinical signs. 4 Diagnostic criteria for scleromyxedema 4 1. Generalized papular eruption and sclerodermoid features 2. Microscopic triad of mucin deposition, fibroblast proliferation and fibrosis 3. Monoclonal gammopathy 4. Absence of thyroid disorder Histopathologic features 3  Diffuse dermal mucin deposition  Increased collagen  Numerous irregularly shaped fibroblasts 6] thalidomide, 7 IVIG, 8 interferon-α and cyclosporine. 9 Therapeutic procedures such as plasmapheresis, 10 radiotherapy, autologous stem cell transplantation, extracorporeal photochemotherapy have also been tried. A combination of BCNU, etoposide, cytarabine and melphalan (BEAM regime) has been recommended prior to autologous stem cell transplantation. 3 Our patient was started on tab methotrexate 7.5 mg/week and betamethasone 0.5 mg (6tab/week). The patient reported mild improvement in sensation of tightness over face and shoulders after 3 months of treatment, however cutaneous lesions were persistent.
